Werewolf Therapeutics notifies Nasdaq of audit committee noncompliance after board member’s passing
NegativeFinancial Markets

Werewolf Therapeutics has informed Nasdaq about a noncompliance issue regarding its audit committee following the recent passing of a board member. This situation raises concerns about the company's governance and oversight, which are crucial for maintaining investor confidence and regulatory compliance. The loss of a board member can impact decision-making processes, and how the company addresses this challenge will be closely watched by stakeholders.
— Curated by the World Pulse Now AI Editorial System